PACTR201709002592834已完成未知
A randomized controlled trial of pregnancy outcome of sequential versus day 3 and day 5 embryo transfers in cases with recurrent implantation failure
Airforce specialized hospital0 个研究点目标入组 210 人开始时间: 2017年9月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 210
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 Year(s) 至 35 Year(s)（—）
- 性别
- Female
入选标准
- •Age 35 years or less
- •Normal endometrial cavity on hysteroscopy
- •Recurrent (2 or more) implantation failure
- •Negative thrombophilia screening
- •No hydrosalpinx
- •No endometriosis
- •Day 3 FSH < 10IU/L and Estradiol <80 pg/mL
- •Antimullerian hormone 1-3 ng/mL
- •Availability of at least 5 embryos on postfertilization check
排除标准
- •Patients not fulfilling the inclusion criteria
- •Poor or over responders in a previous cycle or by ovarian reserve tests.
研究者
相似试验
已完成
不适用
A randomised controlled trial of a preconception clinic in BarnsleyPregnancy and childbirth: PregnancyPregnancy and ChildbirthPregnancyISRCTN28035939HS R&D Regional Programme Register - Department of Health (UK)200
进行中（未招募）
不适用
Clinical Study to compare the effect of two different vaginal application forms of the hormone progesterone (Cyclogest® Pessary and Crinone® 8% Gel) on pregnancy rates after artificial fertilization.uteal phase support after IVFEUCTR2013-001105-81-BGActavis Group PTC ehf.766
进行中（未招募）
1 期
Clinical Study to compare the effect of two different vaginal application forms of the hormone progesterone (Cyclogest® Pessary and Crinone® 8% Gel) on pregnancy rates after artificial fertilization.uteal phase support after IVFEUCTR2013-001105-81-CZActavis Group PTC ehf.766
进行中（未招募）
不适用
Clinical Study to compare the effect of two different vaginal application forms of the hormone progesterone (Cyclogest® Pessary and Crinone® 8% Gel) on pregnancy rates after artificial fertilization.EUCTR2013-001105-81-HUActavis Group PTC ehf.766
进行中（未招募）
1 期
Clinical Study to compare the effect of two different vaginal application forms of the hormone progesterone (Cyclogest® Pessary and Crinone® 8% Gel) on pregnancy rates after artificial fertilization.uteal phase support after IVFEUCTR2013-001105-81-BEActavis Group PTC ehf.766